Recombinant Mortierella alpina Palmitoyltransferase AKR1

What is Mortierella alpina Palmitoyltransferase AKR1?

Mortierella alpina Palmitoyltransferase AKR1 is an enzyme (EC 2.3.1.-) also known as Ankyrin repeat-containing protein AKR1. It is a full-length protein consisting of 559 amino acids derived from the oleaginous fungus Mortierella alpina (also referred to as Mortierella renispora) . This enzyme belongs to the transferase family that forms carbon-sulfur bonds, specifically functioning as an acyltransferase. The protein contains characteristic ankyrin repeat domains which typically mediate protein-protein interactions and are commonly found in proteins involved in diverse cellular functions including signal transduction and metabolism .

Mortierella alpina itself is a zygomycete known for its ability to accumulate lipids up to 50% of its dry weight in the form of triacylglycerols and is industrially important for the production of polyunsaturated fatty acids (PUFAs), particularly arachidonic acid (ARA) . Within this metabolic context, the AKR1 protein likely plays a role in lipid metabolism pathways.

How is Recombinant Mortierella alpina Palmitoyltransferase AKR1 typically expressed and purified?

Recombinant Mortierella alpina Palmitoyltransferase AKR1 is typically expressed in E. coli expression systems. Commercial preparations often include an N-terminal His-tag to facilitate purification . The expression vector contains the complete coding sequence (residues 1-559) of the protein under the control of a strong promoter suitable for bacterial expression .

For purification, standard affinity chromatography techniques using Ni-NTA or similar matrices are employed to isolate the His-tagged protein. After initial purification, additional chromatographic steps may be necessary to achieve high purity. The purified protein is typically provided in a lyophilized form or in a stabilizing buffer containing 50% glycerol .

For researchers preparing their own recombinant protein, optimizing expression conditions (temperature, IPTG concentration, induction time) is crucial for maximizing yield while maintaining proper folding. Given the presence of potential transmembrane domains, careful consideration of solubilization and refolding strategies may be necessary to obtain functionally active protein.

What is the presumed role of Palmitoyltransferase AKR1 in PUFA biosynthesis in Mortierella alpina?

While the specific role of Palmitoyltransferase AKR1 in PUFA biosynthesis is not explicitly detailed in the provided literature, we can contextualize its function within the known metabolic framework of Mortierella alpina. As a palmitoyltransferase, AKR1 likely participates in the transfer of palmitoyl groups to substrate molecules, potentially playing a role in the complex lipid synthesis pathways leading to PUFA production .

Mortierella alpina is known for its elaborate PUFA synthesis pathway, particularly for arachidonic acid (ARA) production. This pathway involves sequential desaturase and elongase-catalyzed steps starting from acetyl-CoA precursors . The genome-scale metabolic model of M. alpina has identified key components in this pathway, including the critical role of NADPH and acetyl-CoA availability .

Palmitoyltransferases often participate in protein modifications that affect membrane targeting or protein-protein interactions. Given the membrane-associated nature of fatty acid synthesis and modification enzymes, AKR1 may be involved in regulating the localization or activity of proteins involved in PUFA biosynthesis through palmitoylation .

What experimental approaches are recommended for assessing Palmitoyltransferase AKR1 activity in vitro?

For assessing the enzymatic activity of Palmitoyltransferase AKR1 in vitro, several complementary approaches are recommended:

• Radioactive Labeling Assay: Using 3H or 14C-labeled palmitoyl-CoA as a substrate and monitoring the transfer of the labeled palmitoyl group to potential acceptor substrates. This approach provides high sensitivity but requires specialized facilities for handling radioactive materials.

• Click Chemistry-Based Assays: Utilizing alkyne or azide-modified palmitoyl-CoA analogs that can be conjugated to fluorescent reporters after the transfer reaction, allowing non-radioactive detection of palmitoyltransferase activity.

• HPLC or LC-MS Analysis: Quantifying the conversion of substrates to products using chromatographic separation coupled with appropriate detection methods. This approach is particularly valuable for identifying the specific molecular species modified by AKR1.

• Coupled Enzyme Assays: Designing assays that link the palmitoyltransferase activity to other enzymatic reactions that produce measurable signals, such as fluorescence or absorbance changes.

When conducting these assays, researchers should carefully consider the following parameters to ensure reliable results:

• Optimal pH and buffer conditions

• Appropriate detergent concentration for enzyme solubilization

• Metal ion requirements (potential cofactors)

• Substrate concentration range for determining kinetic parameters

• Temperature and reaction time optimization

How can researchers optimize expression conditions to improve yield and activity of recombinant AKR1?

Optimizing expression of Recombinant Mortierella alpina Palmitoyltransferase AKR1 requires a systematic approach addressing multiple factors that affect protein yield and activity:

• Expression System Selection:

  • While E. coli is commonly used , consider alternative expression systems like yeast or insect cells for membrane-associated proteins that may require eukaryotic post-translational modifications.

  • Evaluate different E. coli strains designed for membrane protein expression (C41, C43) or strains with additional tRNAs for rare codons.

• Expression Vector Optimization:

  • Select appropriate promoters (T7, tac) based on desired expression level.

  • Optimize codon usage for the expression host.

  • Test different fusion tags beyond His-tag (MBP, SUMO) that may improve solubility.

• Culture Conditions:

  • Temperature: Lower temperatures (16-20°C) often improve proper folding of complex proteins.

  • Induction timing: Induce at optimal cell density (typically mid-log phase).

  • Inducer concentration: Titrate IPTG concentration (typically 0.1-1.0 mM) to find optimal level.

  • Media composition: Rich media (TB, 2YT) versus minimal media, depending on the specific requirements.

• Extraction and Purification:

  • For membrane-associated proteins like AKR1, test various detergents for solubilization.

  • Optimize lysis conditions (sonication, pressure-based lysis, enzymatic lysis).

  • Implement a multi-step purification strategy to achieve high purity.

• Refolding Strategies (if expressed as inclusion bodies):

  • Gradient dialysis to slowly remove denaturants.

  • On-column refolding during purification.

  • Rapid dilution methods to minimize aggregation during refolding.

After expression, perform activity assays to confirm functionality, as high yield does not necessarily correlate with properly folded, active enzyme.

What are the recommended storage conditions for maintaining stability of Recombinant Mortierella alpina Palmitoyltransferase AKR1?

Based on manufacturer recommendations, the following storage conditions should be implemented to maintain optimal stability of Recombinant Mortierella alpina Palmitoyltransferase AKR1:

Long-term Storage:

• Store at -20°C or -80°C for extended periods .

• The protein is typically provided in a stabilizing buffer containing Tris-based components and 50% glycerol .

• For lyophilized preparations, ensure storage in a desiccated environment to prevent moisture absorption .

Working Stock Handling:

• Prepare small working aliquots to avoid repeated freeze-thaw cycles, which can significantly reduce enzyme activity .

• Working aliquots can be stored at 4°C for up to one week .

• When reconstituting lyophilized protein, use deionized sterile water to a concentration of 0.1-1.0 mg/mL .

• Addition of 5-50% glycerol to the final solution is recommended before aliquoting for long-term storage .

Stability Considerations:

• Brief centrifugation of vials before opening is recommended to bring contents to the bottom, particularly for lyophilized preparations .

• Monitor for signs of protein degradation if stored for extended periods.

• Consider adding protease inhibitors for additional stability during experimentation.

Implementing these storage protocols will help maintain the structural integrity and enzymatic activity of Recombinant Mortierella alpina Palmitoyltransferase AKR1 throughout your research project.

How can researchers verify the functionality of recombinant Palmitoyltransferase AKR1 after expression?

Verifying the functionality of recombinant Palmitoyltransferase AKR1 after expression is critical to ensure that experimental results are valid and reproducible. A multi-tiered approach to functionality assessment is recommended:

• Preliminary Quality Assessment:

  • SDS-PAGE analysis to confirm protein purity and expected molecular weight (approximately 62 kDa for the full-length protein plus tag) .

  • Western blot using anti-His antibodies (for His-tagged versions) or specific antibodies against AKR1.

  • Circular dichroism spectroscopy to evaluate secondary structure integrity.

• Enzymatic Activity Assays:

  • Primary activity assay using palmitoyl-CoA and appropriate substrate.

  • Kinetic parameter determination (Km, Vmax) to compare with literature values or previous preparations.

  • Comparative activity testing against known palmitoyltransferases with similar substrates.

• Substrate Specificity Testing:

  • Assay activity with various acyl-CoA donors (palmitoyl-CoA, myristoyl-CoA, stearoyl-CoA) to establish substrate preference profile.

  • Test multiple potential protein or lipid acceptors to determine acceptor substrate specificity.

• Inhibition Studies:

  • Challenge with known palmitoyltransferase inhibitors to confirm expected inhibition patterns.

  • Test sensitivity to metal chelators if metal ion cofactors are required.

• Thermal Stability Assessment:

  • Differential scanning fluorimetry (DSF) to determine melting temperature.

  • Activity retention after controlled heat challenge at various temperatures.

By implementing this comprehensive validation workflow, researchers can ensure that their recombinant Palmitoyltransferase AKR1 preparation possesses the expected biochemical properties and is suitable for downstream applications in studying lipid metabolism in Mortierella alpina.

What technical challenges should researchers anticipate when working with Recombinant Mortierella alpina Palmitoyltransferase AKR1?

Researchers working with Recombinant Mortierella alpina Palmitoyltransferase AKR1 should anticipate several technical challenges inherent to this protein's biochemical properties:

• Solubility and Stability Issues:

  • As a membrane-associated protein with potential transmembrane domains, AKR1 may exhibit limited solubility in aqueous buffers .

  • The protein may be prone to aggregation during concentration steps.

  • Stability may decrease rapidly after reconstitution from lyophilized form without proper additives.

• Expression Challenges:

  • Potential toxicity to expression hosts due to membrane disruption.

  • Formation of inclusion bodies requiring complex refolding strategies.

  • Variable yield depending on expression conditions and strain selection.

• Enzymatic Activity Considerations:

  • Requirement for specific lipid environments to maintain native conformation and activity.

  • Potential cofactor dependencies not fully characterized in the literature.

  • Limited commercially available substrates for activity assays.

• Structural Characterization Difficulties:

  • Challenges in obtaining crystal structures due to membrane association.

  • Difficulty in applying standard structural biology techniques like NMR to this relatively large protein.

• Experimental Design Complications:

  • Need for specialized detergents or reconstitution into liposomes for activity studies.

  • Potential interference of detergents with activity assays.

  • Reproducibility challenges when working with different protein preparations.

Researchers can address these challenges by:

• Implementing careful buffer optimization with stabilizing agents

• Using detergent screening to identify optimal solubilization conditions

• Considering membrane mimetic systems (nanodiscs, liposomes) for functional studies

• Developing robust purification protocols with minimal exposure to harsh conditions

• Preparing larger batches of homogeneous protein to ensure consistency across experiments

How should researchers interpret data from experiments involving Palmitoyltransferase AKR1 in the context of PUFA metabolism?

When interpreting data from experiments involving Palmitoyltransferase AKR1 in the context of PUFA metabolism, researchers should consider several key aspects:

• Metabolic Context Integration:

  • Evaluate findings within the framework of M. alpina's complex lipid metabolism network .

  • Consider the interconnections between AKR1 activity and other enzymes in the PUFA synthesis pathway, including desaturases and elongases that operate sequentially in ARA production .

  • Analyze how AKR1 activity correlates with cellular concentrations of acetyl-CoA and NADPH, which are critical factors in PUFA biosynthesis .

• Data Correlation Approaches:

  • Establish relationships between AKR1 activity and PUFA production rates.

  • Compare experimental findings with predictions from genome-scale metabolic models of M. alpina .

  • Consider performing flux balance analysis (FBA) or flux variability analysis (FVA) to contextualize experimental results within the broader metabolic network .

• Multi-omics Data Integration:

  • Combine enzymatic activity data with transcriptomics, proteomics, and metabolomics data to build a comprehensive understanding.

  • Look for correlations between AKR1 expression levels and changes in lipid profiles.

  • Apply systems biology approaches to identify emergent properties not apparent from isolated experiments.

• Experimental Controls and Benchmarks:

  • Compare results against known rate-limiting steps in PUFA biosynthesis.

  • Use malic enzyme activity as a benchmark, as it has been established as a key component in ARA production .

  • Consider oxygen availability effects, as oxygen uptake rate significantly impacts PUFA unsaturation levels .

The table below summarizes key metabolic parameters to consider when interpreting AKR1 experimental data:

What approaches are recommended for analyzing potential contradictions in experimental results involving Palmitoyltransferase AKR1?

When faced with contradictory results in experiments involving Palmitoyltransferase AKR1, researchers should implement a systematic troubleshooting and analysis approach:

• Methodological Validation:

  • Verify protein quality across different preparations using SDS-PAGE and activity assays .

  • Confirm assay reproducibility through multiple independent replicates.

  • Evaluate the impact of different buffer compositions, pH values, and assay conditions on activity measurements.

  • Consider fundamental differences between in vitro and in vivo experimental systems.

• Statistical Analysis Framework:

  • Apply appropriate statistical tests based on data distribution and experimental design.

  • Utilize outlier detection methods to identify potentially anomalous data points.

  • Calculate confidence intervals to determine the reliability of measurements.

  • Consider Bayesian approaches when integrating prior knowledge with new experimental findings.

• Systematic Variation Analysis:

  • Implement design of experiments (DOE) methodology to systematically explore factors affecting AKR1 activity.

  • Develop response surface models to understand how multiple variables interact to influence enzyme behavior.

  • Use principal component analysis (PCA) to identify patterns in multivariate data sets that might explain apparent contradictions.

• Technical Considerations:

  • Evaluate potential protein stability issues across different experimental conditions .

  • Consider the impact of freeze-thaw cycles on enzyme activity .

  • Assess whether recombinant tag positions (N-terminal vs C-terminal) affect enzyme function .

  • Investigate substrate quality and purity as potential sources of variability.

• Biological Context Evaluation:

  • Consider whether contradictory results might reflect actual biological regulation mechanisms.

  • Evaluate potential context-dependent functions of AKR1 in different metabolic states.

  • Assess whether observed contradictions align with known regulatory patterns in PUFA metabolism .

How can Recombinant Mortierella alpina Palmitoyltransferase AKR1 be utilized in metabolic engineering applications?

Recombinant Mortierella alpina Palmitoyltransferase AKR1 presents several opportunities for metabolic engineering applications, particularly in systems designed to enhance or modify PUFA production:

• PUFA Production Enhancement:

  • Overexpression of AKR1 could potentially increase fatty acid modification capacity if this enzyme represents a rate-limiting step in specific palmitoylation reactions relevant to PUFA synthesis .

  • Co-expression with other key enzymes involved in PUFA biosynthesis might create synergistic effects that enhance productivity.

  • Integration into heterologous hosts could potentially transfer aspects of M. alpina's exceptional lipid production capabilities to industrial organisms.

• Pathway Engineering Strategies:

  • Targeted modification of AKR1 substrate specificity through protein engineering could potentially alter fatty acid profiles.

  • Expression of AKR1 variants with modified regulatory properties might bypass natural feedback inhibition mechanisms.

  • Systems biology approaches using genome-scale metabolic models could predict optimal intervention points involving AKR1 for maximizing PUFA production .

• Process Optimization Applications:

  • Immobilized AKR1 could potentially serve in biocatalytic applications for specific modification of fatty acids or lipids.

  • Development of biosensors incorporating AKR1 domains might enable real-time monitoring of relevant metabolites in production systems.

  • In vitro enzymatic systems combining multiple enzymes including AKR1 might provide novel routes to valuable PUFA derivatives.

• Research Tool Applications:

  • Using recombinant AKR1 to identify interaction partners might reveal new regulatory mechanisms in PUFA metabolism.

  • Structure-function studies with engineered variants could elucidate the molecular basis of substrate specificity.

  • Development of specific inhibitors based on AKR1 structure could provide valuable research tools for dissecting metabolic pathways.

When designing metabolic engineering strategies involving AKR1, researchers should consider the optimal expression conditions established for the recombinant protein and the specific metabolic context of their target system .